Major Depression and Survival in People With Cancer
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Objective: The question of whether depression is associated with worse survival in people with cancer remains unanswered because of methodological criticism of the published research on the topic. We aimed to study the association in a large methodologically robust study. Methods: We analyzed data on 20,582 patients with breast, colorectal, gynecological, lung, and prostate cancers who had attended cancer outpatient clinics in Scotland, United Kingdom. Patients had completed two-stage screening for major depression as part of their cancer care. These data on depression status were linked to demographic, cancer, and subsequent mortality data from national databases. We estimated the association of major depression with survival for each cancer using Cox regression. We adjusted for potential confounders and interactions between potentially time-varying confounders and the interval between cancer diagnosis and depression screening, and used multiple imputation for missing depression and confounder data. We pooled the cancer-specific results using fixed-effects meta-analysis. Results: Major depression was associated with worse survival for all cancers, with similar adjusted hazard ratios (HRs): breast cancer (HR = 1.42, 95% confidence interval [CI] = 1.15–1.75), colorectal cancer (HR = 1.47, 95% CI = 1.11–1.94), gynecological cancer (HR = 1.36, 95% CI = 1.08–1.71), lung cancer (HR = 1.39, 95% CI = 1.24–1.56), and prostate cancer (HR = 1.76, 95% CI = 1.08–2.85). The pooled HR was 1.41 (95% CI = 1.29–1.54, p < .001, I 2 = 0%). These findings were not materially different when we only considered the deaths (90%) that were attributed to cancer. Conclusions: Major depression is associated with worse survival in patients with common cancers. The mechanisms of this association and the clinical implications require further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depression at diagnosis and throughout the cancer trajectory 16 covaries with lower adherence to treatment and follow-up care, increased inflammation, impaired immunity, and reduced survival.17,18”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depression at diagnosis and throughout the cancer trajectory 16 covaries with lower adherence to treatment and follow-up care, increased inflammation, impaired immunity, and reduced survival.17,18”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depression at diagnosis and throughout the cancer trajectory 16 covaries with lower adherence to treatment and follow-up care, increased inflammation, impaired immunity, and reduced survival.17,18”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depression at diagnosis and throughout the cancer trajectory 16 covaries with lower adherence to treatment and follow-up care, increased inflammation, impaired immunity, and reduced survival.17,18”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As is the case for those without cancer, depression and anxiety usually co-occur.30”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083 · cited 1×
“Although two published meta-analyses of the literature (22,23) concluded that depression does predict worse survival, these conclusions have been disputed (24,26,43).”
BackgroundDepression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972 · cited 1×
“Although two published meta-analyses of the literature (22,23) concluded that depression does predict worse survival, these conclusions have been disputed (24,26,43).”
BackgroundDepression and cancer: mechanisms and disease progression
Spiegel, D., & Giese-Davis, J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00566-3 · Cited by 874 · cited 1×
“Why might there be an association between major depression and subsequent survival? One clinically important possible explanation is that depression has a negative causal influence on cancer prognosis, for example, by reducing patients’ adherence to anticancer treatment or by directly influencing the progression of th…”
BackgroundBartlett, J. W., Seaman, S. R., White, I. R., Carpenter, J. R., & Initiative*, F. T. A. D. N. (2015) · Statistical Methods in Medical Research · doi:10.1177/0962280214521348 · Cited by 485
Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., & Sharpe, M. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70313-x · Cited by 435
Self-citationDepression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 375
Prevalence of depression in adults with cancer: a systematic review
Walker, J., Holm Hansen, C., Martin, P., Sawhney, A., Thekkumpurath, P., Beale, C., Symeonides, S., Wall, L., Murray, G., & Sharpe, M. (2013) · Annals of Oncology · doi:10.1093/annonc/mds575 · Cited by 308 · cited 1×
“The prevalence of major depression in our cohort varied by cancer from 5% to 13%, which is similar to that reported by a systematic review of interview-based studies of cancer outpatients (42).”
ResultSelf-citation
Cited by
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
“As is the case for those without cancer, depression and anxiety usually co-occur.(30) Notably, Arch et al(19) found that 31% of patients with cancer with an anxiety disorder also hadmajor depressive disorder (MDD).”
BackgroundAnxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Grassi, L., Caruso, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101155 · Cited by 316
“Both anxiety and depression have been shown to interfere with treatment adherence, and depression has also been associated with poorer prognosis and shorter survival in patients with cancer.(35,36)”
BackgroundGuan, Y., Wang, Y., Yu, H. N., Feng, Y., Zhao, Y., Zhan, X., & Wang, Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79583 · Cited by 83
“Depression is a risk factor for the incidence and death of cancer [24, 25], to investigate the potential promoting role of chronic stress on colorectal cancer development, we took advantage of chronic restraint stress models as described previously [11] (Figure S1A).”
Ungvari, Z. I., Fekete, M., Buda, A., Lehoczki, A., Fekete, J. T., Varga, P., Ungvari, A., & Győrffy, B. (2025) · GeroScience · doi:10.1007/s11357-025-01676-9 · Cited by 64
“In this analysis, eight studies were included to examine the relationship between depression and prostate cancer mortality [33, 35, 72–77].”
Chan, J. K. N., Solmi, M., Lo, H. K. Y., Chan, M. W. Y., Choo, L. L. T., Lai, E. T. H., Wong, C. S. M., Correll, C. U., & Chang, W. C. (2025) · World Psychiatry · doi:10.1002/wps.21354 · Cited by 65
Metadata
- Authors
- Walker, J., Mulick, A., Magill, N., Symeonides, S., Gourley, C., Burke, K., Belot, A., Quartagno, M., van Niekerk, M., Toynbee, M., Frost, C., & Sharpe, M.
- Affiliations
- Edinburgh Cancer Research (GB)
- Corresponding author
- Walker, Jane
- ORCID
- Venue
- Psychosomatic Medicine
- Published
- 2021-04-30
- Volume
- 83
- Issue
- 5
- Pages
- 410-416
- ISSN
- 0033-3174 (ISSN-L)
- 1534-7796
- PMC
- PMC7614901
- OpenAlex
- W3158985447
- Cited by
- 124
- References
- 44
- Citations by year
- 2026: 35 · 2025: 30 · 2024: 22 · 2023: 20 · 2022: 14 · 2021: 3
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Funders
- Cancer Research UK (C5547\A7375, 29018, 18525)
- Medical Research Council (MC_UU_00004/07)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- major depressive disorder, cancer survival, cancer-specific mortality, breast cancer, colorectal cancer, gynecologic cancer, lung cancer, prostate cancer, depression screening, time-varying confounding, cancer patients
- MeSH terms
- Breast Neoplasms, Depression, Major Depressive Disorder, United Kingdom, Humans, Male, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Major Depression and Survival in People With Cancer. https://app.cochat.ai/papers/10.1097/psy.0000000000000942
- The paper
- Walker, J., Mulick, A., Magill, N., Symeonides, S., Gourley, C., Burke, K., Belot, A., Quartagno, M., van Niekerk, M., Toynbee, M., Frost, C., & Sharpe, M. (2021). Major Depression and Survival in People With Cancer. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000000942
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.